JTO Clinical and Research Reports

Published by: Elsevier BV  

People

  1. Riely
    Riely
  2. Adusumilli
    Adusumilli
  3. Bott
    Bott
  4. Chaft
    Chaft
  5. Drilon
    Drilon
  6. Ginsberg
    Ginsberg
  7. Offin
    Offin
  8. Ostroff
    Ostroff
  9. Rekhtman
    Rekhtman
  10. Rudin
    Rudin

Groups

  1. Department of Medicine (16)
  2. Solid Tumor Oncology Division (15)
  3. Thoracic Oncology (15)
  4. Department of Pathology and Laboratory Medicine (9)
  5. Surgery (8)
  6. Weinberg Fellows (8)
  7. Biostatistics Service (7)
  8. Epidemiology and Biostatistics (7)
  9. Radiology, Department of (7)
  10. Survivorship Research (6)
Search Within
Formats
  1. Journal Article (24)
Groups
  1. Department of Medicine (16)
  2. Solid Tumor Oncology Division (15)
  3. Thoracic Oncology (15)
  4. Department of Pathology and Laboratory Medicine (9)
  5. Surgery (8)
  6. Weinberg Fellows (8)

More Groups

People
  1. Gregory Riely (5)
  2. Prasad Adusumilli (4)
  3. Alexander Drilon (3)
  4. Charles Rudin (3)
  5. Etay Ziv (3)
  6. Helena Yu (3)

More People

Years
  1. 2025 (5)
  2. 2024 (4)
  3. 2023 (7)
  4. 2022 (6)
  5. 2021 (2)
Publishers
  1. Elsevier BV (19)
  2. Elsevier B.V. (5)

Results (24)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Spontaneous bilateral chylothorax development during alectinib therapy for ALK-rearranged NSCLC—A case report
    Journal Article

    Bajaj, S.; Chow, A.; Drilon, A.; Kalchiem-Dekel, O.
    JTO Clinical and Research Reports (2023)

    Fulltext@MSK | Save
  • Intracranial outcomes of de novo brain metastases treated with osimertinib alone in patients with newly diagnosed EGFR-mutant NSCLC
    Journal Article

    Imber, B. S.; Sehgal, R.; Saganty, R.; Reiner, A. S.; Ilica, A. T.; Miao, E.; Li, B. T.; Riely, G. J.; Yu, H. A.; Panageas, K. S.; more...
    JTO Clinical and Research Reports (2023)

    Fulltext@MSK | Save
  • Effective communication about lung cancer screening without iatrogenic stigma: A brief report case study using the lung cancer stigma communications assessment tool of LungTalk
    Journal Article

    Carter-Bawa, L.; Ostroff, J. S.; Hoover, K.; Studts, J. L.
    JTO Clinical and Research Reports (2023)

    Fulltext@MSK | Save
  • Patient-reported health-related quality of life in KEYNOTE-604: Pembrolizumab or placebo added to etoposide and platinum as first-line therapy for extensive-stage SCLC
    Journal Article

    Kim, H. R.; Awad, M. M.; Navarro, A.; Gottfried, M.; Peters, S.; Csőszi, T.; Cheema, P. K.; Rodriguez-Abreu, D.; Wollner, M.; Yang, J. C. H.; more...
    JTO Clinical and Research Reports (2023)

    Fulltext@MSK | Save
  • Lorlatinib tolerability and association with clinical outcomes in patients with advanced ALK- or ROS1-rearranged NSCLC: A brief report
    Journal Article

    Thummalapalli, R.; Choudhury, N. J.; Ehrich, F.; Beardslee, T.; Brazel, D.; Zhang, S. S.; Merchant, S.; Chen, M. F.; Heller, G.; Ramalingam, S. S.; more...
    JTO Clinical and Research Reports (2023)

    Fulltext@MSK | Save
  • A phase 1 safety study of avelumab plus stereotactic body radiation therapy in malignant pleural mesothelioma
    Journal Article

    Rimner, A.; Adusumilli, P. S.; Offin, M. D.; Solomon, S. B.; Ziv, E.; Hayes, S. A.; Ginsberg, M. S.; Sauter, J. L.; Gelblum, D. Y.; Shepherd, A. F.; more...
    JTO Clinical and Research Reports (2023)

    Fulltext@MSK | Save
  • High-dose osimertinib for CNS progression in EGFRþ NSCLC: A multi-institutional experience
    Journal Article

    Piper-Vallillo, A. J.; Rotow, J. K.; Aredo, J. V.; Shaverdashvili, K.; Luo, J.; Carlisle, J. W.; Husain, H.; Muzikansky, A.; Heist, R. S.; Rangachari, D.; more...
    JTO Clinical and Research Reports (2022)

    Fulltext@MSK | Save
  • Brief report: Safety and antitumor activity of alectinib plus atezolizumab from a phase 1b study in advanced ALK-positive NSCLC
    Journal Article

    Kim, D. W.; Gadgeel, S.; Gettinger, S. N.; Riely, G. J.; Oxnard, G. R.; Mekhail, T.; Schmid, P.; Dowlati, A.; Heist, R. S.; Wozniak, A. J.; more...
    JTO Clinical and Research Reports (2022)

    Fulltext@MSK | Save
  • National Cancer Institute Smoking Cessation at Lung Examination trials brief report: Baseline characteristics and comparison with the U.S. general population of lung cancer screening–eligible patients
    Journal Article

    Meza, R.; Jeon, J.; Jimenez-Mendoza, E.; Mok, Y.; Cao, P.; Foley, K. L.; Chiles, C.; Ostroff, J. S.; Cinciripini, P. M.; Minnix, J.; more...
    JTO Clinical and Research Reports (2022)

    Fulltext@MSK | Save
  • Brief report: Contralateral lobectomy for second primary NSCLC: Perioperative and long-term outcomes
    Journal Article

    Choe, J. K.; Zhu, A.; Byun, A. J.; Zheng, J.; Tan, K. S.; Dycoco, J.; Bains, M. S.; Bott, M. J.; Downey, R. J.; Huang, J.; more...
    JTO Clinical and Research Reports (2022)

    Fulltext@MSK | Save

    • JTO Clinical and Research Reports – authorized name for:

    Name ISSN / ISBN Publisher
    JTO Clinical and Research Reports 26663643 2024
    Jto Clinical and Research Reports Elsevier Inc.
    Jto Clinical and Research Reports Elsevier Inc.
    JTO Clinical and Research Reports 2666-3643 Elsevier B.V.
    JTO Clinical and Research Reports 2666-3643 Elsevier B.V.
    JTO Clinical and Research Reports 2666-3643 Elsevier BV
    JTO Clinical and Research Reports 2666-3643 Elsevier B.V.
    JTO Clinical and Research Reports 2666-3643 Elsevier B.V.
    JTO Clinical and Research Reports 26663643 The Authors
    JTO Clinical and Research Reports 2666-3643 Elsevier BV